AlAujan SS, et al. - Researchers herein used three screening tools in order to determine the prevalence of fibromyalgia (FM) in pharmacy students and professionals as well as investigated factors linked with its development. In addition, they examined the level of agreement between the tools and the magnitude of the participants’ responses to each item in the screening tools. In this cross-sectional survey conducted on members of the Saudi Pharmaceutical Society using an online questionnaire, following three questionnaires were administered to participants: the London Fibromyalgia Epidemiology Study Screening Questionnaire (LFESSQ), Fibromyalgia Rapid Screening Tool (FiRST) and Fibromyalgia Survey Questionnaire (FSQ). Among 293 participants accessing the survey, most were Saudi (93.5%) and females (78.8%) with a mean (standard deviation) age of 29 (8) years. Generalised body pain was described by 52% of the participants. Per Fleiss’ kappa coefficient, there was fair agreement among all three screening tools. After adjusting for significant variables, the resulting adjusted odds ratio of developing FM was 4.86 in people working for 41– 45 h weekly, 5.16 in people who frequently wake up during sleep and 12.99 in people with sleep apnea or other sleeping disorders. Findings overall suggest prevalence of FM among pharmacy students and professionals and the prevalence was much greater than data reported on the general population or other healthcare workers.